COMMUNIQUÉS West-GlobeNewswire

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025
Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27 th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – [...]
Artelo Biosciences Announces Proposed Underwritten Public Offering
03/09/2025
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Sotera Health Announces Secondary Offering of Common Stock
03/09/2025
CLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 20,000,000 shares of its common stock, par value $ [...]
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
03/09/2025
HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral [...]
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
03/09/2025
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 août 2025
03/09/2025
VALNEVA Déclaration d’actions et de droits de vote 31 août 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 rue [...]
VALNEVA Declaration of shares and voting rights: August 31, 2025
03/09/2025
VALNEVA Declaration of shares and voting rights August 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
Society for Science Recognizes Top 300 Middle School Innovators in Nation’s Premier STEM Competition
03/09/2025
A new generation of STEM stars—tackling topics from sustainability and artificial intelligence to disease detection—has been named to the Thermo Fisher Scientific Junior Innovators Challenge Top 300 WASHINGTON, Sept. 03 [...]
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
03/09/2025
AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram’s Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief Executive [...]
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
03/09/2025
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal [...]
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
03/09/2025
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal [...]
Microbix Hosts Ontario Minister Stephen Crawford
03/09/2025
Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga MISSISSAUGA, Ontario, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences [...]
New Study: Gut Health Program Cuts Infant Eczema Odds by 83% in C-Section Babies
03/09/2025
Randomized trial of 54 infants shows precision gut health support dramatically reduces microbiome risks of allergic disease AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study found that babies born by C- [...]
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
03/09/2025
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony [...]
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025
Live webcast presentation with CEO, Dr. Marc Hertz, on September 9 th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company [...]
Limited Healthcare Access Leaves Families Paying the Price
03/09/2025
New data from WellNow Urgent Care reveals more than seven in 10 mothers surveyed have skipped essentials like rent or food to pay for medical needs CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- As economic pressures [...]
Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis
03/09/2025
Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System SAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first [...]
Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation
03/09/2025
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Persephoni BioSciences LLC ("Persephoni"), a leading global life sciences venture studio, is proud to announce a $1.5 million sponsorship to American [...]
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
03/09/2025
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif., Sept. 03, 2025 (GLOBE [...]

Pages